NSN 6505-01-691-6941 · NIIN 016916941 · FSC 6505
NO DASHES 6505016916941
In Stock
TENECTEPLASE FOR INJECTION KIT
Drugs and Biologicals
Technical characteristics
2 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | TENECTEPLASE INTRAVENOUS KIT, 50MG |
| FEAT | SPECIAL FEATURES | INDICATED FOR USE IN THE REDUCTION OF MORTALITY ASSOCIATED WITH ACUTE MYOCARDIAL INFARCTION (AMI); TISSUE PLASMINOGEN ACTIVATOR (TPA) PRODUCED BY RECOMBINANT DNA TECHNOLOGY USING AN ESTABLISHED MAMMALIAN CELL LINE (CHINESE HAMSTER OVARY CELLS); STORE LYOPHILIZED TNKASE AT CONTROLLED ROOM TEMPERATURE NOT TO EXCEED 30 C (86 F) OR UNDER REFRIGERATION 2 TO 8 C (36 TO 46 F); DO NOT USE BEYOND THE EXPIRATION DATE STAMPED ON THE VIAL; FOR USE IN MYOCARDIAL INFARCTION; FOR INTRAVENOUS ADMINISTRATION ONLY; EACH KIT CONTAINS ONE 50 MG VIAIAL OF TNKASE, ONE 10 ML VIAL OF PRESERVATIVE-FREE STERILE WATER FOR INJECTION, USP, ONE BD 10 ML SYRINGE WITH TWINPAK DUAL CANNULA DEVICE, AND PACKAGE INSERT CONTAINING FULL PRESCRIBING INFORMATION; VIAL CONTENTS: THE PRESERVATIVE-FREE SINGLE-USE VIAL OF TNKASE CONTAINS 52.5 MG TENECTEPLASE, 0.55 G L-ARGININE, 0.17 G PHOSPHORIC ACID, AND 4.3 MG POLYSORBATE 20, UNDER PARTIAL VACUUM. NO U.S. STANDARD OF POTENCY; 36 MONTHS SHELF LIFE. |